LDL-Apheresis in Homozygous LDL-Receptor-Defective Familial Hypercholesterolemia: The Munich Experience
- 1 December 2009
- journal article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (5) , 21-26
- https://doi.org/10.1016/s1567-5688(09)71805-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Efficacy criteria and cholesterol targets for LDL apheresisPublished by Elsevier ,2009
- Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial HypercholesterolemiaThe American Journal of Cardiology, 2008
- Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial HypercholesterolemiaThe American Journal of Cardiology, 2008
- Low‐density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow‐up to 21 YearsTherapeutic Apheresis and Dialysis, 2008
- Vascular Calcifications in Homozygote Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemiaThe American Journal of Cardiology, 1996
- Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresisJournal of Molecular Medicine, 1986
- Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.BMJ, 1985
- Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue cultureAtherosclerosis, 1985
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1975